Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer

Bararia, Akash; Chakraborty, Prosenjeet; Roy, Paromita; Chattopadhay, Bitan Kumar; Das, Amlan; Chatterjee, Aniruddha; Sikdar, Nilabja

doi:10.3748/wjg.v29.i15.2241

Cited by 7 publications

(2 citation statements)

References 120 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…WJG v29i15: The articles are interesting overall. For “Editor’s choice” papers, I especially like two: (1) Pancreatic cancer topic: “Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer”[ 37 ], because of the importance of the topic; and (2) Gastrointestinal barrier dysfunction topic: “Mechanisms of gastrointestinal barrier dysfunction in COVID-19 patients”[ 38 ].…”

Section: Hot Articles and Insufficient Articlesmentioning

confidence: 99%

Editor-in-Chief articles of choice and comments at the year-end of 2023

Tarnawski

2024

World J Gastroenterol

View full text Add to dashboard Cite

As the Editor-in-Chief, every week prior to a new issue’s online publication, I perform a careful review of all encompassed articles, including the title, clinical and/or research importance, originality, novelty, and ratings by the peer reviewers. Based on this review, I select the papers of choice and suggest pertinent changes (e.g. , in the title) to the Company Editors responsible for publication. This process, while time-consuming, is very important for assuring the quality of publications and highlighting important articles that Readers may revisit.

show abstract

Section: Hot Articles and Insufficient Articlesmentioning

confidence: 99%

Editor-in-Chief articles of choice and comments at the year-end of 2023

Tarnawski

2024

World J Gastroenterol

View full text Add to dashboard Cite

show abstract

“…Thus, there are high expectations for using microvesicles isolated from serum or FNA to diagnose pancreatic cancer. A recently published review by Bararia et al provides a comprehensive description of the novel biomarkers that have the potential to be used as noninvasive means of discriminating pancreatic cancer from precancerous lesions, thereby improving the diagnosis of early stage PDAC [ 51 ].…”

Section: Improvements To Current Diagnostic Approachesmentioning

confidence: 99%

Advances in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma and Premalignant Pancreatic Lesions

et al. 2023

View full text Add to dashboard Cite

Pancreatic cancer is one of the most lethal human malignancies, in part because it is often diagnosed at late stages when surgery and systemic therapies are either unfeasible or ineffective. Therefore, diagnosing pancreatic cancer in earlier stages is important for effective treatment. However, because the signs and symptoms may be nonspecific and not apparent until the disease is at a late stage, the timely diagnoses of pancreatic cancer can be difficult to achieve. Recent studies have shown that selective screening and increased usage of biomarkers could improve the early diagnosis of pancreatic cancer. In this review, we discuss recent advancements in the early detection of pancreatic ductal carcinoma and precancerous lesions. These include innovations in imaging modalities, the diagnostic utility of various biomarkers, biopsy techniques, and population-based surveillance approaches. Additionally, we discuss how machine learning methods are being applied to develop integrated methods of identifying individuals at high risk of developing pancreatic disease. In the future, the overall survival of pancreatic cancer patients could be improved by the development and adoption of these new methods and techniques.

show abstract